157 related articles for article (PubMed ID: 37226562)
21. Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients.
Funayama N; Muratsubaki S; Ito R; Tobisawa T; Konishi T
Heart Vessels; 2023 Mar; 38(3):300-308. PubMed ID: 36045267
[TBL] [Abstract][Full Text] [Related]
22. Comparison of drug-eluting stents vs. drug-coated balloon after rotational atherectomy for severely calcified lesions of nonsmall vessels.
Iwasaki Y; Koike J; Ko T; Funatsu A; Kobayashi T; Ikeda T; Nakamura S
Heart Vessels; 2021 Feb; 36(2):189-199. PubMed ID: 32857188
[TBL] [Abstract][Full Text] [Related]
23. Two-year clinical outcomes of zotarolimus- and everolimus-eluting durable-polymer-coated stents versus biolimus-eluting biodegradable-polymer-coated stent in patients with acute myocardial infarction with dyslipidemia after percutaneous coronary intervention: data from the KAMIR.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Heart Vessels; 2019 Feb; 34(2):237-250. PubMed ID: 30167772
[TBL] [Abstract][Full Text] [Related]
24. Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions.
Abdel-Wahab M; Baev R; Dieker P; Kassner G; Khattab AA; Toelg R; Sulimov D; Geist V; Richardt G
Catheter Cardiovasc Interv; 2013 Feb; 81(2):285-91. PubMed ID: 22431433
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Drug-Coated Balloon Approaches for
Zhong PY; Ma Y; Shang YS; Niu Y; Bai N; Wang ZL
Front Cardiovasc Med; 2022; 9():899701. PubMed ID: 35800174
[TBL] [Abstract][Full Text] [Related]
26. A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions.
Kook H; Joo HJ; Park JH; Hong SJ; Yu CW; Lim DS
BMC Cardiovasc Disord; 2020 Feb; 20(1):83. PubMed ID: 32070287
[TBL] [Abstract][Full Text] [Related]
27. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
[TBL] [Abstract][Full Text] [Related]
28. Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease.
Megaly M; Buda K; Saad M; Tawadros M; Elbadawi A; Basir M; Abbott JD; Rinfret S; Alaswad K; Brilakis ES
Cardiovasc Revasc Med; 2022 Feb; 35():76-82. PubMed ID: 33858783
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
30. Impact of Drug-Coated Balloon-Based Revascularization in Patients with Chronic Total Occlusions.
Shin ES; Her AY; Jang MH; Kim B; Kim S; Liew HB
J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38929910
[No Abstract] [Full Text] [Related]
31. First- versus second-generation drug-eluting stents for the treatment of coronary bifurcations.
Costopoulos C; Latib A; Ferrarello S; Naganuma T; Sticchi A; Filippo F; Giannini F; Basavarajaiah S; Kawaguchi M; Naim C; Candreva A; Carlino M; Chieffo A; Montorfano M; Colombo A
Cardiovasc Revasc Med; 2013; 14(6):311-5. PubMed ID: 24157311
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents.
Sim HW; Ananthakrishna R; Chan SP; Low AF; Lee CH; Chan MY; Tay EL; Loh PH; Chan KH; Tan HC; Loh JP
J Invasive Cardiol; 2018 Jul; 30(7):256-261. PubMed ID: 29656281
[TBL] [Abstract][Full Text] [Related]
33. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA
J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881
[TBL] [Abstract][Full Text] [Related]
34. Drug-coated balloon in the treatment of coronary left main true bifurcation lesion: A patient-level propensity-matched analysis.
Pan L; Lu W; Han Z; Pan S; Wang X; Shan Y; Peng M; Qin X; Sun G; Zhang P; Dong J; Qiu C
Front Cardiovasc Med; 2022; 9():1028007. PubMed ID: 36407423
[TBL] [Abstract][Full Text] [Related]
35. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
[TBL] [Abstract][Full Text] [Related]
36. Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute.
Yu X; Ji F; Xu F; Zhang W; Wang X; Lu D; Yang C; Wang F
Clin Res Cardiol; 2019 Mar; 108(3):234-243. PubMed ID: 30074078
[TBL] [Abstract][Full Text] [Related]
37. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
39. A Propensity Score-Matched Comparison of Midterm Outcomes Between Drug-Coated Balloons and Drug-Eluting Stents for Patients with Acute Coronary Syndrome.
Mizutani Y; Ishikawa T; Nakamura H; Yamada K; Shimura M; Kondo Y; Ukaji T; Aoki H; Hisauchi I; Itabashi Y; Nakahara S; Taguchi I
Int Heart J; 2022 Mar; 63(2):217-225. PubMed ID: 35185090
[TBL] [Abstract][Full Text] [Related]
40. Drug-coated balloons for the treatment of stent edge restenosis.
Nagasaka T; Amanai S; Ishibashi Y; Aihara K; Ohyama Y; Takama N; Koitabashi N; Ishii H
Coron Artery Dis; 2023 Jun; 34(4):236-243. PubMed ID: 36951740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
